Medicare Coverage For Leqembi: Timeline For Reconsideration Of Restrictions

 
• By Cathy Kelly

After getting a formal request for Medicare to reconsider coverage for Eisai’s new drug and other mAbs, CMS must decide by mid February whether to undertake the process. The formal timeline for reconsideration runs six to 12 months; past reviews have taken around nine months.

Eisai Optimistic That Reconsideration Won't Take Too Long • Source: Shutterstock

More from Market Access

More from Pink Sheet